Meynert基底核刺激治疗路易体痴呆:一项I期随机临床试验
该随机双盲交叉I期试验纳入6例轻中度路易体痴呆患者,行双侧Meynert基底核脑深部电刺激(NBM-DBS),比较主动刺激与假刺激3个月的效果。主要结局FCSRT自由回忆总分无显著差异,主动刺激后音素流畅性和运动障碍较基线显著下降,但电极植入后Stroop和Benton评分显著降低。结论认为NBM-DBS对路易体痴呆患者并非完全安全,且无认知获益证据。
要点
- NBM-DBS未改善路易体痴呆患者的选择性回忆评分。
- 电极植入后Stroop和Benton评分显著下降,提示安全性问题。
- 主动刺激后音素流畅性和运动障碍较基线显著下降。
核心结论
- NBM-DBS对路易体痴呆患者并非完全安全,且无认知获益证据。
研究设计与样本
- 随机双盲交叉I期临床试验,纳入6例轻中度路易体痴呆患者(平均年龄62.2岁,SD 7.8),行双侧NBM-DBS,主动与假刺激各3个月。
主要发现
- 主动与假刺激相比,FCSRT自由回忆总分无显著差异。
- 电极植入后Stroop和Benton评分显著下降。
- 主动刺激较基线音素流畅性和运动障碍显著下降。
- 主动刺激较假刺激其他量表无显著差异。
- 主动刺激后优势舌回代谢活动显著增加。
临床怎么用
- 目前证据不支持将NBM-DBS用于路易体痴呆的认知改善。
- 临床决策时应充分告知电极植入后认知评分下降的风险。
局限性
- 样本量小(6例),为I期探索性试验。
- 交叉设计周期较短(3个月)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Nucleus basalis of Meynert deep brain stimulation (NBM-DBS) has been proposed for patients with dementia. Here, we aim to assess the safety and effects of NBM-DBS in patients with Lewy body dementia (LBD), in a randomized, double-blind, crossover clinical trial. METHODS: Six patients with mild to moderate LBD (mean [SD] age, 62.2 [7.8] years) were included, operated on for bilateral NBM-DBS, and assigned to receive either active or sham NBM-DBS followed by the opposite condition for 3 months. The primary outcome was the difference in the total free recalls of the Free and Cued Selective Reminding Test (FCSRT) between active and sham NBM-DBS. Secondary outcomes were assessments of the safety and effects of NBM-DBS on cognition, motor disability, sleep, and PET imaging. RESULTS: There was no significant difference in the FCSRT score with active vs sham NBM-DBS. The surgical procedures were well tolerated in all patients, but we observed significant decreases in Stroop and Benton scores after electrode implantation. We observed no significant difference in other scales between active and sham NBM-DBS. With active NBM-DBS relative to baseline, phonemic fluency and motor disability significantly decreased. Lastly, the superior lingual gyrus metabolic activity significantly increased with active NBM-DBS. CONCLUSIONS: NBM-DBS does not appear to be totally safe for patients with LBD with no evidence of cognitive benefit. CLINICALTRIALSGOV IDENTIFIER: NCT01340001. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that, for patients with LBD operated on for bilateral NBM-DBS, active NBM-DBS stimulation compared to sham stimulation did not significantly change selective recall scores.
引用
- Maltête D, Wallon D, Bourilhon J, et al. Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial. Neurology. 2020. PMID: 33199437. doi:10.1212/WNL.0000000000011227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。